Company intelligence / Profile preview

Gnacode

Ownership: Private
Development stage: Commercial

Overview

Gnacode develops advanced laboratory instrumentation including the RAPGNA diagnostic system, Minicube PCR machine with asynchronous multi-well control, DBACC aerosol conditioning front-end to mass spectrometry, and plasma-based sterilization devices. Their products are designed to improve flexibility, precision, and throughput in molecular biology labs. The Minicube PCR allows 16 independent protocols simultaneously with app-based remote control. Devices are commercially available.

Modalities: DeviceDiagnostic devicePCR technology (for research and diagnostics)Plasma sterilization device
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Gnacode.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gnacode.

Explore the full profile